Mucocutaneous leishmaniasis (Q38463): Difference between revisions

← Older edit

@@ Property / CURIE @@
+CID11:1F54.2
@@ Property / CURIE: CID11:1F54.2 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-1F54.2
@@ Property / Canary Token: dki-india-1F54.2 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank
@@ Property / Linked ICD 10 @@
+B55.2
@@ Property / Linked ICD 10: B55.2 / rank @@
+Normal rank

Latest revision as of 03:31, 13 August 2026

Mucocutaneous leishmaniasis is a secondary infection of nasal and oral mucosae, predominantly by Leishmania braziliensis. It usually first manifests within two years of initial cutaneous infection but often after the latter has healed. It results from lymphatic or haematogenous spread of infection and can cause severe local tissue destruction.

Language	Label	Description	Also known as
default for all languages	1F54.2
English	Mucocutaneous leishmaniasis	Mucocutaneous leishmaniasis is a secondary infection of nasal and oral mucosae, predominantly by Leishmania braziliensis. It usually first manifests within two years of initial cutaneous infection but often after the latter has healed. It results from lymphatic or haematogenous spread of infection and can cause severe local tissue destruction.